Clinical Trial Update: The StoneBreakerTM Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for StoneBreaker in nephrolithiasis undergoing percutaneous nephrolithotripsy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: University of British Columbia | Conditions: Percutaneous Nephrolithotripsy | Phase 3 | Status: COMPLETED